Email address
eveline.vankeymeulen@lw.comContact number
+32.2.788.6000Share profile
Band 2
Provided by Eveline Van Keymeulen
Eveline Van Keymeulen is a partner in Latham & Watkins' Brussels and Paris offices and Global Vice Chair of Latham & Watkins' Healthcare & Life Sciences Practice.
She advises multinational companies and start-ups in the pharmaceutical, biotech, medical devices, cosmetics, and food and beverage sectors on a broad variety of complex European, domestic and cross-border regulatory matters, including clinical trials, product approvals, regulatory incentives, market access, promotion and advertising, post-market obligations, and general compliance matters.
In addition, Eveline has extensive experience advising on cannabis and hemp-based product regulations. She successfully challenged the legality of French hemp regulations in the first landmark case related to cannabidiol (CBD) products before the Court of Justice of the European Union (Case C-663/18, Kanavape). This transaction won the Creating New Standards award at the Financial Times European Innovative Lawyer Awards 2022.
Eveline has authored numerous articles and has been a featured speaker on EU regulatory matters at prominent conferences such as the Pharmaceutical Law Academy in Cambridge. She also serves on the editorial board of the European Pharmaceutical Law Review.
In addition, Eveline has been quoted in BBC Business Daily, Bloomberg, The Times, Les Echos, and other leading international business journals on life sciences regulatory and policy matters.
Provided by Chambers
Eveline Van Keymeulen of Latham & Watkins is recognised for her comprehensive regulatory practice, advising major pharmaceutical and technology clients.
Eveline Van Keymeulen de Latham & Watkins est reconnue pour sa pratique réglementaire, conseillant d’importants clients pharmaceutiques et du secteur de la technologie.
Provided by Chambers
Her commitment to fostering an inclusive team environment and providing clear, actionable advice has significantly enhanced our overall experience with the firm.
Eveline brings an exceptional depth of knowledge in healthcare and life sciences, combined with a proactive approach that makes navigating complex regulatory challenges much more manageable.
Eveline a une connaissance exceptionnelle de la santé et des sciences de la vie, combinée à une approche proactive qui rend les défis réglementaires complexes beaucoup plus facile à gérer.
Son engagement à favoriser un environnement d’équipe inclusif et à fournir des conseils clairs et concrets a considérablement facilité notre expérience globale avec le cabinet.
Her commitment to fostering an inclusive team environment and providing clear, actionable advice has significantly enhanced our overall experience with the firm.
Eveline brings an exceptional depth of knowledge in healthcare and life sciences, combined with a proactive approach that makes navigating complex regulatory challenges much more manageable.
Eveline a une connaissance exceptionnelle de la santé et des sciences de la vie, combinée à une approche proactive qui rend les défis réglementaires complexes beaucoup plus facile à gérer.
Son engagement à favoriser un environnement d’équipe inclusif et à fournir des conseils clairs et concrets a considérablement facilité notre expérience globale avec le cabinet.